Assignee
GN CORP CO LTD
JP·0 granted patents·5 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
5 records- 0156US2024226136A1A composition for improving, preventing and/or treating muscular dystrophy, multiple sclerosis and/or related diseasesGN CORP CO LTD·Filed 2022·Application pending·0 cites
- 0255US2024285672A1Beta-glucan for preventing and/or treating fibrosis and related diseasesGN CORP CO LTD·Filed 2022·Application pending·0 cites
- 0354US2024374631A1A composition for improving gut microbiota, behavioural pattern, alpha-synuclein levels, sleep pattern and/or serum melatoninGN CORP CO LTD·Filed 2022·Application pending·0 cites
- 0450US2023233596A1Beta-glucan for immuno-enhancement and/or immuno-balancing, and for adjuvant useGN CORP CO LTD·Filed 2021·Application pending·0 cites
- 0549US2023092155A1Chondrocyte culture with high tissue regeneration abilityGN CORP CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GN CORP CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →